{
    "clinical_study": {
        "@rank": "133037", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      Determine the efficacy of midodrine, a selective alpha 1 adrenergic agonist, in preventing\n      neurally mediated syncope."
        }, 
        "brief_title": "Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope", 
        "condition": "Syncope", 
        "condition_browse": {
            "mesh_term": "Syncope"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: This is a randomized, double-blind, crossover, placebo-controlled study.\n\n      On day one, patients receive either midodrine or placebo.  On day three, patients receive\n      the opposite drug."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics-- Diagnosis of neurally mediated syncope (vasovagal fainting)\n        Sudden fall in blood pressure AND Slowing of the heart AND Temporary loss of consciousness\n        AND Hemodynamic response to head up tilt --Prior/Concurrent Therapy-- No other concurrent\n        adrenergic agonist or antiagonist --Patient Characteristics-- Fertile patients must use\n        effective birth control"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004479", 
            "org_study_id": "199/14181", 
            "secondary_id": [
                "MTS-GCO-97-160NE", 
                "ROBERTS-MTS-GCO-97-160NE"
            ]
        }, 
        "intervention": {
            "intervention_name": "midodrine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Adrenergic alpha-Agonists", 
                "Midodrine", 
                "Adrenergic Agonists"
            ]
        }, 
        "keyword": [
            "neurologic and psychiatric disorders", 
            "rare disease", 
            "syncope"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10029"
                }, 
                "name": "Mount Sinai School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "overall_official": {
            "affiliation": "Mount Sinai School of Medicine", 
            "last_name": "Horacio Kaufmann", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Unspecified"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004479"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mount Sinai School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 1999", 
        "study_design": "Allocation: Randomized, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2004"
    }, 
    "geocoordinates": {
        "Mount Sinai School of Medicine": "40.714 -74.006"
    }
}